Femasys Inc., a leading biomedical innovator in women's health, announced its intention to offer and sell shares of its common stock in a public offering, with the option for underwriters to purchase an additional 15% of the shares. Concurrently, certain existing institutional stockholders and company directors and officers have shown interest in a private placement of shares. The offerings aim to fund the company's commercial expansion, product development, and general corporate purposes. JonesTrading Institutional Services LLC is managing the public offering and private placement. The public offering is registered under a statement filed with the U.S. Securities and Exchange Commission.